News & Events

Want the latest updates delivered to your inbox?
Subscribe to our newsletter.

News
  • Published: 2. Feb 2026

RGCC Advocates for Equal Patient Access to Advanced Therapy Medicinal Products (ATMPs) Across the European Union

RGCC aims to promote transparency and collective action toward a fair and unified approach to healthcare access across the…

News
  • Published: 11. Dec 2025

As part of its CSR activities, RGCC Donates €15,000 to Support CAR-T Cell Therapy Research at Charité – Universitätsmedizin Berlin

RGCC International announces a €15,000 donation to Charité – Universitätsmedizin Berlin to support pioneering CAR-T cell therapy research for…

News
  • Published: 5. Dec 2025

New Study Demonstrates Benefits of Circulating Tumor Cell Analysis in Ovarian Cancer Care

Powered by RGCC’s Onconomics test, circulating tumor cell (CTC) analysis is transforming ovarian cancer care — helping doctors personalize…

News
  • Published: 12. Nov 2025

RGCC Supports “Kinder-Hilfe-Mobil” Initiative to Aid Children in Need in Halle (Saale), Germany

RGCC Central Europe has announced its support for CVJM Halle e. V., an organization dedicated to helping children living…

News
  • Published: 30. May 2025

RGCC Signs Letter of Intent to Foster Academic Collaboration with Universitas Hasanuddin and PT Wapindo Jasaartha

RGCC International is proud to announce the signing of a Letter of Intent (LoI) with Universitas Hasanuddin in Indonesia…

News
  • Published: 3. Mar 2025

RGCC International Announces the Launch of InVyomma Plus: A Revolutionary Gut Microbiome Profiling Test

RGCC International is proud to announce the launch of its latest test, InVyomma Plus. The test is designed to…

News
  • Published: 11. Feb 2025

RGCC International at DMCCB Basel Symposium 2025: Celebrating Excellence in Cancer Research

RGCC International is honored to have participated in the DMCCB Basel Symposium 2025.

News
  • Published: 9. Jan 2025

As part of its Corporate Social Responsibility activities, RGCC International Donates CHF 15,000 to Universitäts-Kinderspital Zürich

As part of its ongoing commitment to Corporate Social Responsibility (CSR), RGCC International is proud to announce a donation…

News
  • Published: 7. Nov 2024

RGCC and PERABOI Sign MOU for a Clinical Study on Circulating Tumor Cells in Breast Cancer

October 4th, 2024 – Bali, Indonesia: RGCC, a leader in advanced diagnostic technologies, and the Indonesian Association of Surgical…

News
  • 21. May 2024

RGCC SA laboratory in Greece receives prestigious certification from Japan’s Ministry Of Health, Labour and Welfare

Japan

RGCC SA is proud to announce that our state-of-the-art laboratory in Greece has been awarded the accreditation certificate of…